Curated watchlist · external investor
Jim Roppel
Jun 8Roppel's tracked names, scored by our engine. His list, our read — not his live trades.
| Ticker | Price | Chg% | Quality | RS | Setup | Triggered | Status |
|---|---|---|---|---|---|---|---|
| $194.83 | -1.39% | 85 | 57 | No setup | — | Hold | |
| $245.29 | -9.84% | 61 | 95 | No setup | — | Watch | |
| $1213.91 | +1.86% | 92 | 77 | Near pivot | — | Hold | |
| $64.62 | +4.31% | 11 | 2 | No setup | — | Avoid | |
| $422.46 | -8.65% | 86 | 98 | No setup | — | Hold | |
| $209.31 | +0.01% | 65 | 84 | Watch | — | Watch | |
| $112.69 | -3.69% | 65 | 80 | Watch | — | Watch | |
| $1769.32 | -4% | 81 | 90 | No setup | — | Hold | |
| $603.04 | -7.35% | 75 | 95 | Watch | — | Hold | |
| $241.91 | -6.63% | 96 | 93 | No setup | — | Hold | |
| $32.18 | +0.88% | 75 | 87 | Base breakout | — | Hold | |
| $1113.11 | -1.87% | 82 | 90 | No setup | — | Hold | |
| $194.67 | -1.56% | 80 | 55 | Near pivot | — | Hold | |
| $270.89 | -6.43% | 80 | 99 | No setup | — | Hold | |
| $333.36 | -9.57% | 72 | 96 | No setup | — | Hold | |
| $582.9 | -4.9% | 66 | 17 | No setup | — | Watch | |
| $34.64 | +3.59% | 66 | 88 | ②Pullback | 2026-07-02 · 1d | Watch② | |
| $96.14 | -1.89% | 42 | 20 | Near pivot | — | Avoid | |
| $112.73 | +3.76% | 41 | 48 | Watch | — | Avoid | |
| $72.16 | -1.57% | 34 | 41 | Watch | — | Avoid | |
| $48.68 | +2.53% | 33 | 76 | No setup | — | Avoid | |
| $192.01 | +1.66% | 27 | 16 | Watch | — | Avoid |
Roppel's latest — key learnings
Investing With IBD · 2026-06-08The market is in the early stages of a massive AI-driven bull run, despite a recent sharp pullback after 9 consecutive weeks of gains. While a more 'normal' bull market with 4-10% corrections is expected for the rest of the year, the underlying technological tsunami of innovation, particularly in AI, is just getting started and will lead to significantly higher highs and massive prosperity. Jim Roppel is bullish long-term, anticipating a Q4 rebound after a period of basing.
- •Risk management
- •Position sizing
- •Lean into history
- •Understand market cycles
- •Sell in chunks
- •Never freeze up (sell something)
- •Acceptance of situation
- •Stick with quality (99 comp quality)
- →Prioritize sound money and risk management, including position sizing and protecting your cost basis with strict stop-losses (3-7% down, you're out).
- →Expect market pullbacks and corrections, even in strong bull markets; use them as opportunities to re-evaluate and buy quality.
- →Focus on high-quality companies with strong fundamentals (sales, earnings, margins) and liquidity, especially when the market gets frothy.
- →Never freeze up when selling; if a stock breaks key support (like the 50-day MA), sell in chunks to manage the position.
- →Be patient and disciplined: avoid buying extended stocks or IPOs without a proper base, as 'no base, no buy.'
- →Understand the long-term historical context of massive technological shifts like AI; compound for the long pull to build significant wealth.
Mentioned as part of the AI buildout, though had a 'false breakout' recently.
Pounded the table on this one, showing relative strength and leadership; a best-performing stock that never let him down.
Owns it, a 'wonder drug' (retatrutide) with broad applications beyond weight loss; company uses AI (Lily Pod) for drug discovery, leading to many new drugs.
Ranted about it previously, imploded, used as an example of needing risk management (below 140 was a no-go zone).
Has a very big AI project, competitor to Lilly in drug discovery.
Caught in a losing trade after earnings, broke 50-day, used as an example of how to sell in chunks when late.
Mentioned as a stock showing pockets of strength during the pullback.
Mentioned as a stock showing pockets of strength during the pullback.
Closed up nicely, showing pockets of strength during the pullback.
Loved it fundamentally and technically, came raging out after the correction, a strong leader.
Not as good as AMAT but technically looks like it's shaping up.
Came out today (implies watching/interest).